ES2038829T3 - Antidotos. - Google Patents

Antidotos.

Info

Publication number
ES2038829T3
ES2038829T3 ES198989310487T ES89310487T ES2038829T3 ES 2038829 T3 ES2038829 T3 ES 2038829T3 ES 198989310487 T ES198989310487 T ES 198989310487T ES 89310487 T ES89310487 T ES 89310487T ES 2038829 T3 ES2038829 T3 ES 2038829T3
Authority
ES
Spain
Prior art keywords
antidotes
compounds
flupropadine
chlorpromazine
depressants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989310487T
Other languages
English (en)
Inventor
Russell Nicholson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of ES2038829T3 publication Critical patent/ES2038829T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE PRESENTAN ANTIDOTOS PARA EL RATICIDA DE FLUPROPADINO Y SUSTANCIAS QUE ACTUEN DE LA MISMA FORMA. EL ANTIDOTO INCLUYE COMPUESTOS QUE MODULAN (POR EJ. INHIBEN) LOS SISTEMAS AMINERGICOS EN EL INTESTINO O LOS TEJIDOS ADRENALES. DICHOS COMPUESTOS INCLUYEN ANTIDEPRESANTES TRICICLICOS (POR. EJ. CLOROPROMACINA) Y MUCHOS OTROS.
ES198989310487T 1988-10-13 1989-10-12 Antidotos. Expired - Lifetime ES2038829T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888824050A GB8824050D0 (en) 1988-10-13 1988-10-13 Antidotes

Publications (1)

Publication Number Publication Date
ES2038829T3 true ES2038829T3 (es) 1993-08-01

Family

ID=10645158

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989310487T Expired - Lifetime ES2038829T3 (es) 1988-10-13 1989-10-12 Antidotos.

Country Status (9)

Country Link
US (1) US5023073A (es)
EP (1) EP0371598B1 (es)
JP (1) JPH02134330A (es)
AT (1) ATE76749T1 (es)
AU (1) AU622934B2 (es)
DE (1) DE68901711T2 (es)
ES (1) ES2038829T3 (es)
GB (1) GB8824050D0 (es)
GR (1) GR3005068T3 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50207026D1 (de) * 2001-08-23 2006-07-06 Bayer Cropscience Sa Substituierte propargylamine
US7653108B2 (en) * 2004-09-09 2010-01-26 Hewlett-Packard Development Company, L.P. Apparatus and method of establishing optical communication channels between a steerable array of laser emitters and an array of optical detectors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA813127B (en) * 1980-05-13 1982-05-26 May & Baker Ltd A new phenylpropargylamine derivative

Also Published As

Publication number Publication date
EP0371598A1 (en) 1990-06-06
EP0371598B1 (en) 1992-06-03
JPH02134330A (ja) 1990-05-23
GR3005068T3 (es) 1993-05-24
DE68901711T2 (de) 1992-12-17
GB8824050D0 (en) 1988-11-23
ATE76749T1 (de) 1992-06-15
DE68901711D1 (de) 1992-07-09
US5023073A (en) 1991-06-11
AU4285089A (en) 1990-04-26
AU622934B2 (en) 1992-04-30

Similar Documents

Publication Publication Date Title
MX9202546A (es) Dimeros de rapamicina y composicion farmaceutica que los contiene.
MX9201950A (es) Composiciones de bronceado artificial que contienen vesiculas paucilaminares positivamente cargadas.
DK421189D0 (da) Granulatkorn til indeslutning i et brusepraeparat samt brusepraeparat indeholdende saadanne granulatkorn
DE68912237T2 (de) Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung.
DE3888809D1 (de) Gerät zur Verdampfung von Desinfektionsmitteln.
DE68914856T3 (de) Synergetische Antioxydationsmischung.
FI910123A0 (fi) Polymerkomposition foer att avlaegsna syre.
DE69114350D1 (de) Strahlteilungs-/-vereinigungsvorrichtung.
MX9203099A (es) N-heterociclico-n-(4-piperidia)amidas y composiciones farmaceuticas y metodos que emplean dichos compuestos.
NO891746D0 (no) Konserveringsmiddel.
MX9201710A (es) Carbamatos de rapamicina y composicion farmaceutica que los contiene.
ATE126666T1 (de) Imazalil enthaltende synergistische zusammensetzungen.
MX24890A (es) Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene.
NO881109D0 (no) Middel til innsekt- og middbeskyttelse.
BR9002916A (pt) Mistura fotoendurecivel e material de registro fotoendurecivel obtido da mesma
ES2038829T3 (es) Antidotos.
IT1237478B (it) Perfezionata composizione pesticida.
FR2652742B1 (fr) Compositions anallergiques cosmetiques et dermo-pharmaceutiques.
NO885640D0 (no) Framgangsmaate og sammensetninger for katodisk beskyttelse.
NO903633L (no) Innretning og fremgangsmaate for bekjempelse av barkbiller.
DE68912215D1 (de) Aerosolzusammensetzung.
DE69200210T2 (de) Klebrigkeitsprüfer.
ES2060092T3 (es) Raticida.
FR2674097B1 (fr) Dispositif de protection d'arbres.
MX9202908A (es) Derivado de benzoilurea y composicion insecticida que lo contiene.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 371598

Country of ref document: ES